DocDollars

Soleno Therapeutics, Inc.

CA · United States · Reporting entity ID 100000196839

Total reported 2019–2025
$8.05M
#560 of 2,960 reporting companies — 0% of all reported industry payments
$419K in general payments across 2,010 records, plus $7.63M in research funding across 186 records.

How it breaks down

General payments $419,015
Research funding $7,628,956

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Soleno Therapeutics, Inc. reported $8.05M to US doctors and teaching hospitals from 2019 to 2025, ranking #560 of 2,960 reporting companies. 95% of that was research funding and 5% general payments such as consulting, speaking, food and travel. 2,010 general payment records and 186 research records were filed.

Common questions about Soleno Therapeutics, Inc.

How much has Soleno Therapeutics, Inc. paid US doctors?

Soleno Therapeutics, Inc. reported $8,047,971 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $419,015 in general payments, $7,628,956 in research funding.

How does Soleno Therapeutics, Inc. rank among drug and device companies?

It ranks #560 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Soleno Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.